Role of NKT Cells During Viral Infection and the Development of NKT Cell-Based Nanovaccines

Overview

Journal Vaccines (Basel)

Date 2021 Sep 28

PMID 34579186

Citations 14

Authors

Masood Alam Khan

Arif Khan

Affiliations

Soon will be listed here.

Abstract

Natural killer T (NKT) cells, a small population of T cells, are capable of influencing a wide range of the immune cells, including T cells, B cells, dendritic cells and macrophages. In the present review, the antiviral role of the NKT cells and the strategies of viruses to evade the functioning of NKT cell have been illustrated. The nanoparticle-based formulations have superior immunoadjuvant potential by facilitating the efficient antigen processing and presentation that favorably elicits the antigen-specific immune response. Finally, the immunoadjuvant potential of the NKT cell ligand was explored in the development of antiviral vaccines. The use of an NKT cell-activating nanoparticle-based vaccine delivery system was supported in order to avoid the NKT cell anergy. The results from the animal and preclinical studies demonstrated that nanoparticle-incorporated NKT cell ligands may have potential implications as an immunoadjuvant in the formulation of an effective antiviral vaccine that is capable of eliciting the antigen-specific activation of the cell-mediated and humoral immune responses.

Citing Articles

Can invariant Natural Killer T cells drive B cell fate? a look at the humoral response.

Palacios P, Santibanez A, Aguirre-Munoz F, Gutierrez-Vera C, Nino de Zepeda-Carrizo V, Gongora-Pimentel M Front Immunol. 2025; 16:1505883.

PMID: 40040714 PMC: 11876049. DOI: 10.3389/fimmu.2025.1505883.

Umbilical cord blood stem cells as third-party adjuvant infusions in human leukocyte antigen antibody-positive patients undergoing haploidentical hematopoietic stem cell transplantation.

Wang Y, Zhao Y, Fang X, Yuan D, Ding M, Lu K Front Immunol. 2024; 15:1459699.

PMID: 39399498 PMC: 11466763. DOI: 10.3389/fimmu.2024.1459699.

Natural Killer T Cell Diversity and Immunotherapy.

Tognarelli E, Gutierrez-Vera C, Palacios P, Pasten-Ferrada I, Aguirre-Munoz F, Cornejo D Cancers (Basel). 2023; 15(24).

PMID: 38136283 PMC: 10742272. DOI: 10.3390/cancers15245737.

Dysfunctional states of unconventional T-cell subsets in cancer.

Katsnelson E, Spengler A, Domenico J, Couts K, Loh L, Gapin L J Leukoc Biol. 2023; 115(1):36-46.

PMID: 37837379 PMC: 10843843. DOI: 10.1093/jleuko/qiad129.

Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review.

Zhao X, Amevor F, Xue X, Wang C, Cui Z, Dai S J Nanobiotechnology. 2023; 21(1):121.

PMID: 37029392 PMC: 10081370. DOI: 10.1186/s12951-023-01876-5.

References

Terrazzano G, Bruzzaniti S, Rubino V, Santopaolo M, Palatucci A, Giovazzino A . T1D progression is associated with loss of CD3CD56 regulatory T cells that control CD8 T cell effector functions. Nat Metab. 2020; 2(2):142-152. PMC: 7272221. DOI: 10.1038/s42255-020-0173-1. View

Zeissig S, Murata K, Sweet L, Publicover J, Hu Z, Kaser A . Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med. 2012; 18(7):1060-8. PMC: 3478098. DOI: 10.1038/nm.2811. View

Dwivedi V, Manickam C, Dhakal S, Binjawadagi B, Ouyang K, Hiremath J . Adjuvant effects of invariant NKT cell ligand potentiates the innate and adaptive immunity to an inactivated H1N1 swine influenza virus vaccine in pigs. Vet Microbiol. 2016; 186:157-63. DOI: 10.1016/j.vetmic.2016.02.028. View

Renukaradhya G, Khan M, Shaji D, Brutkiewicz R . Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway. J Virol. 2008; 82(24):12535-42. PMC: 2593331. DOI: 10.1128/JVI.00881-08. View

Wang X, Lei Y, Chen M, Chen C, Ren H, Shi T . PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication. J Viral Hepat. 2013; 20 Suppl 1:27-39. DOI: 10.1111/jvh.12061. View

Kok W, Denney L, Benam K, Cole S, Clelland C, McMichael A . Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection. J Leukoc Biol. 2011; 91(3):357-68. DOI: 10.1189/jlb.0411184. View

Berzins S, Smyth M, Baxter A . Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol. 2011; 11(2):131-42. DOI: 10.1038/nri2904. View

Levy O, Orange J, Hibberd P, Steinberg S, LaRussa P, Weinberg A . Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis. 2003; 188(7):948-53. DOI: 10.1086/378503. View

Diana J, Griseri T, Lagaye S, Beaudoin L, Autrusseau E, Gautron A . NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity. 2009; 30(2):289-99. DOI: 10.1016/j.immuni.2008.12.017. View

10.

Tefit J, Crabe S, Orlandini B, Nell H, Bendelac A, Deng S . Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination. Vaccine. 2014; 32(46):6138-45. PMC: 4233108. DOI: 10.1016/j.vaccine.2014.08.070. View

11.

Tang X, Jo J, Tan A, Sandalova E, Chia A, Tan K . IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J Immunol. 2013; 190(7):3142-52. DOI: 10.4049/jimmunol.1203218. View

12.

Joseph A, Itskovitz-Cooper N, Samira S, Flasterstein O, Eliyahu H, Simberg D . A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice. Vaccine. 2006; 24(18):3990-4006. DOI: 10.1016/j.vaccine.2005.12.017. View

13.

Rao P, Pham H, Kulkarni A, Yang Y, Liu X, Knipe D . Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function. J Virol. 2011; 85(16):8093-104. PMC: 3147970. DOI: 10.1128/JVI.02689-10. View

14.

Ajuebor M . Role of NKT cells in the digestive system. I. Invariant NKT cells and liver diseases: is there strength in numbers?. Am J Physiol Gastrointest Liver Physiol. 2007; 293(4):G651-6. DOI: 10.1152/ajpgi.00298.2007. View

15.

Wu C, Feng Y, Qian G, Wu J, Luo J, Wang Y . α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis. Clin Exp Immunol. 2010; 162(1):178-87. PMC: 2990944. DOI: 10.1111/j.1365-2249.2010.04233.x. View

16.

Paget C, Ivanov S, Fontaine J, Blanc F, Pichavant M, Renneson J . Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia. J Immunol. 2011; 186(10):5590-602. DOI: 10.4049/jimmunol.1002348. View

17.

Khan A, Allemailem K, Almatroodi S, Almatroudi A, Rahmani A . Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications. 3 Biotech. 2020; 10(4):163. PMC: 7062946. DOI: 10.1007/s13205-020-2144-3. View

18.

Syed F, Khan M, Nasti T, Ahmad N, Mohammad O . Antigen entrapped in the escheriosomes leads to the generation of CD4(+) helper and CD8(+) cytotoxic T cell response. Vaccine. 2003; 21(19-20):2383-93. DOI: 10.1016/s0264-410x(03)00106-3. View

19.

Liu Q, Zheng X, Zhang C, Shao X, Zhang X, Zhang Q . Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration. J Med Virol. 2015; 87(11):1807-15. DOI: 10.1002/jmv.24253. View

20.

Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, Core M . Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol. 2010; 11(8):701-8. DOI: 10.1038/ni.1890. View